Overview
Joseph Uberti is an Oncologist practicing medicine in Troy, Michigan. He has been practicing medicine for over 45 years.
Dr. Uberti is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, and Myelodysplastic Syndrome (MDS).
He is actively involved in clinical research, co-authoring 77 peer reviewed articles and participating in 15 clinical trials. Dr. Uberti is currently accepting new patients.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- POS
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1560 E Maple Rd, Troy, MI 48083
4100 John R St, Detroit, MI 48201
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
15 Clinical Trials
Henry Ford Cancer-Detroit
Shirish Gadgeel is an Oncologist practicing medicine in Detroit, Michigan. Dr. Gadgeel is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Squamous Cell Lung Carcinoma, EGFR Positive Lung Cancer, and Tissue Biopsy. Dr. Gadgeel is currently accepting new patients.
Oncology Clinic
Dr. Vaishampayan is the Director of the Phase I program at the Rogel Cancer Center, University of Michigan, Ann Arbor MI. Dr. Vaishampayan is a Professor of Internal Medicine and her research is primarily in translational drug development and early phase clinical trials in cancer with a focus on genitourinary malignancies. She has initiated, obtained funding for, and conducted and published many investigator initiated trials with embedded biomarkers and established multidisciplinary collaboration. She has served as site PI of the UO-1 Early Therapeutics Research Grant at Wayne State University. She was also the chair of the solid tumor division of oncology at WSU. She has completed formal leadership traning course and is Fellow of the Advisory Board (FAB). She is the appointed chair of the Advanced Renal committee of SWOG and a member of the Renal task force of the NCI. She is a board member of the Michigan Society of Hematology/Oncology (MSHO) and organizes annual board review course. Additionally, she has served as track leader for the ASCO education committee GU non prostate (Renal and bladder cancer) track. Dr. Vaishampayan attended Wayne State University for her residency and fellowship completion and attended medical school at Byramjee Jeejeebhoy in Pune, India and completed a higher secondary certificate in the field of science at Fergusson College in Pune, India.In her free time, Dr. Vaishampayan enjoys reading, dance, music and travel. Travel, reading (mysteries preferred), follows football. Dr. Vaishampayan is highly rated in 32 conditions, according to our data. Her clinical expertise encompasses Renal Cell Carcinoma (RCC), Urothelial Cancer, Prostate Cancer, Nephrectomy, and Orchiectomy. Dr. Vaishampayan is board certified in Medical Oncology. Dr. Vaishampayan is currently accepting new patients.
Rogel Cancer Center
Rashmi Chugh is an Oncologist and a Hematologist practicing medicine in Ann Arbor, Michigan. Dr. Chugh is highly rated in 32 conditions, according to our data. Her clinical expertise encompasses Adult Soft Tissue Sarcoma, Epithelioid Sarcoma, Desmoid Tumor, and Ewing Sarcoma. Dr. Chugh is currently accepting new patients.
Frequently Asked Questions about Dr. Joseph P. Uberti
How do I make an appointment with Dr. Joseph P. Uberti?
You can book an appointment with Dr. Joseph P. Uberti by calling their office at 800-527-6266. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Joseph P. Uberti a top-rated expert for Multiple Myeloma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Joseph P. Uberti is classified as an Distinguished expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Joseph P. Uberti specialize in?
While Dr. Joseph P. Uberti is a Oncology, they have specific expertise in Multiple Myeloma, Acute Myeloid Leukemia (AML), and Non-Hodgkin Lymphoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Joseph P. Uberti participate in research or clinical trials?
Yes. Dr. Joseph P. Uberti has published 77 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Dr. Joseph P. Uberti's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Joseph P. Uberti accept my insurance?
Dr. Joseph P. Uberti accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 800-527-6266 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Myeloblastic Leukemia with MaturationDr. Uberti isDistinguished. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Uberti isDistinguished. Learn about Acute Myeloid Leukemia (AML).
- Childhood Acute Myeloid LeukemiaDr. Uberti isDistinguished. Learn about Childhood Acute Myeloid Leukemia.
- Large-Cell Immunoblastic LymphomaDr. Uberti isDistinguished. Learn about Large-Cell Immunoblastic Lymphoma.
- Multiple MyelomaDr. Uberti isDistinguished. Learn about Multiple Myeloma.
- Myelodysplastic Syndrome (MDS)Dr. Uberti isDistinguished. Learn about Myelodysplastic Syndrome (MDS).
- Non-Hodgkin LymphomaDr. Uberti isDistinguished. Learn about Non-Hodgkin Lymphoma.
- Smoldering Multiple MyelomaDr. Uberti isDistinguished. Learn about Smoldering Multiple Myeloma.
- Advanced
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myelomonocytic LeukemiaDr. Uberti isAdvanced. Learn about Acute Myelomonocytic Leukemia.
- Chronic Graft Versus Host Disease (cGvHD)
- Chronic Myelomonocytic Leukemia (CMML)
- Classical Hodgkin LymphomaDr. Uberti isAdvanced. Learn about Classical Hodgkin Lymphoma.
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Gastric LymphomaDr. Uberti isAdvanced. Learn about Gastric Lymphoma.
- Hodgkin LymphomaDr. Uberti isAdvanced. Learn about Hodgkin Lymphoma.
- LeukemiaDr. Uberti isAdvanced. Learn about Leukemia.
- Mantle Cell Lymphoma (MCL)Dr. Uberti isAdvanced. Learn about Mantle Cell Lymphoma (MCL).
- Relapsed Refractory Multiple Myeloma (RRMM)
- T-Cell LymphomaDr. Uberti isAdvanced. Learn about T-Cell Lymphoma.
- Experienced
- Anaplastic Large Cell LymphomaDr. Uberti isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- Angioimmunoblastic T-cell LymphomaDr. Uberti isExperienced. Learn about Angioimmunoblastic T-cell Lymphoma.
- B-Cell LymphomaDr. Uberti isExperienced. Learn about B-Cell Lymphoma.
- Breast CancerDr. Uberti isExperienced. Learn about Breast Cancer.
- Burkitt LymphomaDr. Uberti isExperienced. Learn about Burkitt Lymphoma.
- Chronic B-Cell Leukemia (CBCL)Dr. Uberti isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Dr. Uberti isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Chronic Myelogenous Leukemia (CML)Dr. Uberti isExperienced. Learn about Chronic Myelogenous Leukemia (CML).
- Chronic T-Cell Leukemia (CTCL)Dr. Uberti isExperienced. Learn about Chronic T-Cell Leukemia (CTCL).
- Cutaneous T-Cell Lymphoma (CTCL)Dr. Uberti isExperienced. Learn about Cutaneous T-Cell Lymphoma (CTCL).
- Follicular LymphomaDr. Uberti isExperienced. Learn about Follicular Lymphoma.
- GangliogliomaDr. Uberti isExperienced. Learn about Ganglioglioma.
- Inflammatory Breast CancerDr. Uberti isExperienced. Learn about Inflammatory Breast Cancer.
- Lymphofollicular HyperplasiaDr. Uberti isExperienced. Learn about Lymphofollicular Hyperplasia.
- Marginal Zone Lymphoma (MZL)Dr. Uberti isExperienced. Learn about Marginal Zone Lymphoma (MZL).
- Myeloproliferative Neoplasms (MPN)Dr. Uberti isExperienced. Learn about Myeloproliferative Neoplasms (MPN).
- Peripheral T-Cell LymphomaDr. Uberti isExperienced. Learn about Peripheral T-Cell Lymphoma.
- Philadelphia-Negative Chronic Myeloid Leukemia
- PlasmacytomaDr. Uberti isExperienced. Learn about Plasmacytoma.
- Primary Lymphoma of the BrainDr. Uberti isExperienced. Learn about Primary Lymphoma of the Brain.
- Richter SyndromeDr. Uberti isExperienced. Learn about Richter Syndrome.
- Small Lymphocytic Lymphoma (SLL)Dr. Uberti isExperienced. Learn about Small Lymphocytic Lymphoma (SLL).
- Triple-Negative Breast CancerDr. Uberti isExperienced. Learn about Triple-Negative Breast Cancer.


